{"id":"cggv:664a3eaa-0139-4f5a-8f97-a4a7e00ddfd3v1.0","type":"EvidenceStrengthAssertion","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"cggv:664a3eaa-0139-4f5a-8f97-a4a7e00ddfd3_publish_contrib","agent":"http://dataexchange.clinicalgenome.org/agent/10072","date":"2022-12-31T06:46:06.074Z","role":"Publisher"},{"id":"cggv:664a3eaa-0139-4f5a-8f97-a4a7e00ddfd3_contrib","agent":"http://dataexchange.clinicalgenome.org/agent/10072","date":"2022-09-01T16:00:00.000Z","role":"Approver"}],"earliestArticle":{"id":"https://pubmed.ncbi.nlm.nih.gov/11379879","type":"dc:BibliographicResource","dc:abstract":"Retinitis pigmentosa (RP) is a clinically and genetically heterogeneous group of retinal diseases leading to blindness. By performing full genome linkage analysis in a consanguineous French family affected with severe autosomal recessive RP, we have excluded linkage to known loci involved in RP and mapped a novel locus to chromosome 16q13-q21 (Zmax=2.83 at theta=0 at the D16S3089 locus). Two candidate genes KIFC3 and CNGB1 mapping to this critical interval have been screened for mutations. The CNGB1 gene, which encodes the beta-subunit of the rod cGMP-gated channel, is mutated in the family presented in this study.","dc:creator":"Bareil C","dc:date":"2001","dc:title":"Segregation of a mutation in CNGB1 encoding the beta-subunit of the rod cGMP-gated channel in a family with autosomal recessive retinitis pigmentosa."},"evidence":[{"id":"cggv:664a3eaa-0139-4f5a-8f97-a4a7e00ddfd3_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:664a3eaa-0139-4f5a-8f97-a4a7e00ddfd3_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:ac160df8-0dbd-42fa-8aca-468b7abfdf45","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"cggv:d3b4bedd-2544-42b8-8c26-533e7c70774e","type":"Finding","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"},"dc:description":"Progressive retinal atrophy (PRA) is the canine equivalent of retinitis pigmentosa,\nElectroretinography (ERG) of affected Papillons showed markedly reduced or absent rod-mediated ERG responses from an early age with preservation of cone photoreceptor responses.\nSD-OCT performed on PRA-affected Papillons (confirmed to have theCNG B1 mutation described in this paper) showed that affected dogs have a progressive thinning of the outer nuclear layer with age","dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/23977260","type":"dc:BibliographicResource","dc:abstract":"Retinal dystrophies in dogs are invaluable models of human disease. Progressive retinal atrophy (PRA) is the canine equivalent of retinitis pigmentosa (RP). Similar to RP, PRA is a genetically heterogenous condition. We investigated PRA in the Papillon breed of dog using homozygosity mapping and haplotype construction of single nucleotide polymorphisms within a small family group to identify potential positional candidate genes. Based on the phenotypic similarities between the PRA-affected Papillons, mouse models and human patients, CNGB1 was selected as the most promising positional candidate gene. CNGB1 was sequenced and a complex mutation consisting of the combination of a one basepair deletion and a 6 basepair insertion was identified in exon 26 (c.2387delA;2389_2390insAGCTAC) leading to a frameshift and premature stop codon. Immunohistochemistry (IHC) of pre-degenerate retinal sections from a young affected dog showed absence of labeling using a C-terminal CNGB1 antibody. Whereas an antibody directed against the N-terminus of the protein, which also recognizes the glutamic acid rich proteins arising from alternative splicing of the CNGB1 transcript (upstream of the premature stop codon), labeled rod outer segments. CNGB1 combines with CNGA1 to form the rod cyclic nucleotide gated channel and previous studies have shown the requirement of CNGB1 for normal targeting of CNGA1 to the rod outer segment. In keeping with these previous observations, IHC showed a lack of detectable CNGA1 protein in the rod outer segments of the affected dog. A population study did not identify the CNGB1 mutation in PRA-affected dogs in other breeds and documented that the CNGB1 mutation accounts for ~70% of cases of Papillon PRA in our PRA-affected canine DNA bank. CNGB1 mutations are one cause of autosomal recessive RP making the CNGB1 mutant dog a valuable large animal model of the condition.","dc:creator":"Winkler PA","dc:date":"2013","dc:title":"A large animal model for CNGB1 autosomal recessive retinitis pigmentosa."},"rdfs:label":"Immunohistochemistry in Papillon with PRA"}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2},{"id":"cggv:664a3eaa-0139-4f5a-8f97-a4a7e00ddfd3_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:f0aacc74-2777-4547-87e9-a1ec43480574_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:f0aacc74-2777-4547-87e9-a1ec43480574","type":"Proband","allele":{"id":"cggv:1cd3568d-156c-46b2-80f5-b0608ba84386","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001297.5(CNGB1):c.1589C>G (p.Pro530Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA358282"}},"firstTestingMethod":"Next generation sequencing panels","sex":"Male","variant":{"id":"cggv:01f6e893-6f51-4bdd-ac13-e65e305d4df9_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:1cd3568d-156c-46b2-80f5-b0608ba84386"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/23661369","type":"dc:BibliographicResource","dc:abstract":"Retinitis pigmentosa (RP) is a highly heterogeneous genetic disease; therefore, an accurate molecular diagnosis is essential for appropriate disease treatment and family planning. The prevalence of RP in China had been reported at 1 in 3800, resulting in an estimated total of 340,000 Chinese RP patients. However, genetic studies of Chinese RP patients have been very limited. To date, no comprehensive molecular diagnosis has been done for Chinese RP patients. With the emergence of next-generation sequencing (NGS), comprehensive molecular diagnosis of RP is now within reach. The purpose of this study was to perform the first NGS-based comprehensive molecular diagnosis for Chinese RP patients.","dc:creator":"Fu Q","dc:date":"2013","dc:title":"Next-generation sequencing-based molecular diagnosis of a Chinese patient cohort with autosomal recessive retinitis pigmentosa."}},"rdfs:label":"Patient 4294_1"},{"id":"cggv:01f6e893-6f51-4bdd-ac13-e65e305d4df9","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:01f6e893-6f51-4bdd-ac13-e65e305d4df9_variant_evidence_item"}],"strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:45564167-6c77-4b5b-8bde-d295401792d8_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:45564167-6c77-4b5b-8bde-d295401792d8","type":"Proband","allele":{"id":"cggv:58871028-a72a-442c-8d02-df44407a8c5d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001297.5(CNGB1):c.2957A>T (p.Asn986Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA233760"}},"firstTestingMethod":"Exome sequencing","sex":"Female","variant":{"id":"cggv:73f79fca-27a7-40ca-9f46-3eea627859f0_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:58871028-a72a-442c-8d02-df44407a8c5d"},"alleleOrigin":{"id":"obo:GENO_0000877"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/28056120","type":"dc:BibliographicResource","dc:abstract":"There are limited published data on the phenotype of retinitis pigmentosa (RP) related to CNGB1 variants. These data are needed both for prognostic counseling of patients and for understanding potential treatment windows.","dc:creator":"Hull S","dc:date":"2017","dc:title":"Clinical Characterization of CNGB1-Related Autosomal Recessive Retinitis Pigmentosa."}},"rdfs:label":"Patient 3"},{"id":"cggv:73f79fca-27a7-40ca-9f46-3eea627859f0","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:73f79fca-27a7-40ca-9f46-3eea627859f0_variant_evidence_item"}],"strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:4f61e6e7-7b3a-4244-94f8-5a84a4c17186_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:4f61e6e7-7b3a-4244-94f8-5a84a4c17186","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":30,"allele":{"id":"cggv:3abc0eff-dd66-45be-868d-6b46adcde23c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001297.5(CNGB1):c.2978G>T (p.Gly993Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA254576"}},"detectionMethod":"A genome-wide search for homozygosity was undertaken, and 382 polymorphic markers were tested in this pedigree. The loci previously known to account for autosomal recessive RP were excluded. \nIntronic primers were designed to amplify the 33 exons and flanking introns of CNGB1","firstTestingMethod":"Homozygosity mapping","previousTesting":false,"secondTestingMethod":"PCR","sex":"Female","variant":{"id":"cggv:807b0c8d-cb9d-440d-b4f4-7886e3e9f08d_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:3abc0eff-dd66-45be-868d-6b46adcde23c"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/11379879"},"rdfs:label":"30yrF"},{"id":"cggv:807b0c8d-cb9d-440d-b4f4-7886e3e9f08d","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:807b0c8d-cb9d-440d-b4f4-7886e3e9f08d_variant_evidence_item"}],"strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:ce85d111-2c8c-4b3f-91e5-d396a5379ca9_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:ce85d111-2c8c-4b3f-91e5-d396a5379ca9","type":"Proband","allele":{"id":"cggv:f2dfc1bb-d76c-4734-974d-cc7c8f0b8d17","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001297.5(CNGB1):c.2185C>T (p.Arg729Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA396063476"}},"sex":"Female","variant":{"id":"cggv:06ddd072-a66a-417f-9187-0095534b9904_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:f2dfc1bb-d76c-4734-974d-cc7c8f0b8d17"},"alleleOrigin":{"id":"obo:GENO_0000877"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/28056120"},"rdfs:label":"Patient 9"},{"id":"cggv:06ddd072-a66a-417f-9187-0095534b9904","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:06ddd072-a66a-417f-9187-0095534b9904_variant_evidence_item"}],"strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:37582d65-3095-4aa0-b404-7fa9406adff5_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:37582d65-3095-4aa0-b404-7fa9406adff5","type":"Proband","allele":[{"id":"cggv:97f081a2-3e93-43f6-871d-25bd583dd047","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001297.5(CNGB1):c.952C>T (p.Gln318Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA221645"}},{"id":"cggv:58871028-a72a-442c-8d02-df44407a8c5d"}],"firstTestingMethod":"Exome sequencing","sex":"Female","variant":[{"id":"cggv:77ae599b-deb9-476f-b0b3-491a6a2afeb5_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:97f081a2-3e93-43f6-871d-25bd583dd047"},"alleleOrigin":{"id":"obo:GENO_0000877"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/28056120"},{"id":"cggv:ee9bb494-fdf6-4d76-af65-0b5db3d21bba_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:58871028-a72a-442c-8d02-df44407a8c5d"},"alleleOrigin":{"id":"obo:GENO_0000877"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/28056120"}],"rdfs:label":"Patient 5"},{"id":"cggv:ee9bb494-fdf6-4d76-af65-0b5db3d21bba","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:ee9bb494-fdf6-4d76-af65-0b5db3d21bba_variant_evidence_item"}],"strengthScore":0.1},{"id":"cggv:77ae599b-deb9-476f-b0b3-491a6a2afeb5","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:77ae599b-deb9-476f-b0b3-491a6a2afeb5_variant_evidence_item"}],"strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:498fffc7-d835-4004-a531-43b8209ab32c_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:498fffc7-d835-4004-a531-43b8209ab32c","type":"Proband","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":30,"allele":{"id":"cggv:257e64d0-6653-43d7-89a1-0c0372da9a03","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001297.5(CNGB1):c.3462+1G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/8898"}},"sex":"Male","variant":{"id":"cggv:7e74d484-d885-457b-8fe8-9ca896b26733_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:257e64d0-6653-43d7-89a1-0c0372da9a03"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/15557452","type":"dc:BibliographicResource","dc:abstract":"To identify possible mutations in known candidate genes in patients with autosomal recessive (ar) and simplex retinitis pigmentosa (RP), by using an established strategy of flexible, multiplexed, microsatellite-based homozygosity mapping.","dc:creator":"Kondo H","dc:date":"2004","dc:title":"A homozygosity-based search for mutations in patients with autosomal recessive retinitis pigmentosa, using microsatellite markers."}},"rdfs:label":"patient 02201"},{"id":"cggv:7e74d484-d885-457b-8fe8-9ca896b26733","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:7e74d484-d885-457b-8fe8-9ca896b26733_variant_evidence_item"}],"strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:664a3eaa-0139-4f5a-8f97-a4a7e00ddfd3_seg_el","type":"EvidenceLine","specifiedBy":"GeneValiditySegregationEvidencCriteria","strengthScore":0.5},{"id":"cggv:674995e2-037b-42ed-aee0-ac828355c5e2_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:674995e2-037b-42ed-aee0-ac828355c5e2","type":"Proband","allele":[{"id":"cggv:768a42e0-1e6b-4997-bb88-a6d83a542f64","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001297.5(CNGB1):c.262C>T (p.Gln88Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10581700"}},{"id":"cggv:f299297d-d66c-4141-94e7-4b5eb357471d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001297.5(CNGB1):c.664C>T (p.Gln222Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA396077701"}}],"sex":"Female","variant":[{"id":"cggv:16d73839-161f-47af-ae4d-6f46f0dcd22c_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:768a42e0-1e6b-4997-bb88-a6d83a542f64"},"alleleOrigin":{"id":"obo:GENO_0000877"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/28056120"},{"id":"cggv:d7f015c2-8ae8-4923-99bf-0d9e652abc1d_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:f299297d-d66c-4141-94e7-4b5eb357471d"},"alleleOrigin":{"id":"obo:GENO_0000877"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/28056120"}],"rdfs:label":"Patient 1"},{"id":"cggv:16d73839-161f-47af-ae4d-6f46f0dcd22c","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:16d73839-161f-47af-ae4d-6f46f0dcd22c_variant_evidence_item"}],"strengthScore":1.5},{"id":"cggv:d7f015c2-8ae8-4923-99bf-0d9e652abc1d","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:d7f015c2-8ae8-4923-99bf-0d9e652abc1d_variant_evidence_item"}],"strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:664a3eaa-0139-4f5a-8f97-a4a7e00ddfd3_ar_el","type":"EvidenceLine","specifiedBy":"GeneValidityOverallAutosomalRecessiveVariantEvidenceCriteria","strengthScore":11.1}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":11.6}],"evidenceStrength":"Definitive","sequence":5665,"specifiedBy":"GeneValidityCriteria9","strengthScore":13.6,"subject":{"id":"cggv:b48dedbc-eafc-42f3-962e-d4107dae6cb2","type":"GeneValidityProposition","disease":"obo:MONDO_0800403","gene":"hgnc:2151","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","dc:description":"*CNGB1* was first reported in relation to autosomal recessive retinitis pigmentosa in 2001 (Bareil et al., PMID: 11379879). 8 publications were added with 5 included for evidence (PMIDs: 11379879, 15557452, 23661369, 28056120, and 23977260) in this curation. *CNGB1* variants within the channel‚Äêencoding part of the sequence result in olfactory symptoms, in addition to phenotypes associated with retinitis pigmentosa. Because of the broad spectrum of potential phenotypes, these cases with causal variants in *CNGB1* have been curated under the inclusive disease name *CNGB1*-related retinopathy (MONDO:0800403). More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity is reported to be LOF. This gene-disease association is also supported by experimental evidence.\n\nIn summary, *CNGB1* is definitively associated with *CNGB1*-related retinopathy. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification has been approved by the ClinGen Retina GCEP on September 1st, 2022 (SOP Version 9).","dc:isVersionOf":{"id":"cggv:664a3eaa-0139-4f5a-8f97-a4a7e00ddfd3"},"@context":{"@vocab":"http://dataexchange.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"http://dataexchange.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"http://dataexchange.clinicalgenome.org/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"}}}